Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial

The goal of this observational study is to validate digital mobility outcomes for monitoring the treatment and disease progression in adult patients with pulmonary hypertension. The main question it aims to answer is: -Do digital mobility outcomes (measured digital endpoints characterizing walking behavior) correlate with measures of precapillary pulmonary pressure as assessed by right heart catheterization? Participants will be asked to wear a small sensor on the lower back for one week at a time for a total of 3 times: at diagnosis and follow-up visits at 3-6 months and again at 6-12 months. Follow-up visits are scheduled by the treating clinician. At the end of the study participants can choose to receive feedback on the sensor measurements.

Participants needed: 77
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Simon JägerUpdated: Aug 22, 2025Locations: 4
Eligibility criteria

Pulmonary hypertension confirmed by right heart catheterization [+6]

Hospitalization for a pulmonological disease within the 30 days prior to study r... [+7]

Status: Not yet recruiting

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

The goal of this observational study is to learn about the occurrence of and to identify suitable strategies for screening and monitoring of inner ear damage in patients receiving cisplatin chemoradiotherapy for head and neck cancer. Researchers will compare patients who are receiving cisplatin chemoradiotherapy to patients who are only receiving radiotherapy. Patients will undergo standardized testing for hearing loss, tinnitus and vestibular dysfunction at baseline, during and after treatment. Optional genetic analyses will aim to identify genes known to predispose to cisplatin-induced ototoxicity.

Participants needed: 55
Trial details
Age: 18-85Biological sex: AllType: ObservationalSponsor: Simon JägerUpdated: Apr 16, 2025Locations: 1Duration: 6 Months
Eligibility criteria

Diagnosis of head and neck squamous cell carcinoma [+3]

Severe hearing impairment (WHO grade 3 or 4, corresponding to an audiometric ISO... [+5]